caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992971519

Joseph QureshiM.D.

PRACTICEEYE CARE AND SURGERY PASee all providers at this practice →
OphthalmologyLaurel, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Joseph Qureshi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Wendye Vanbrakle
Ophthalmology · Cumberland, MD
127292
Quest Diagnostics Incorporated Md
Clinical Laboratory · Baltimore, MD
45105
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1535
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1425
SANTIAGO, CARLOS1113
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,026
Unique beneficiaries
—
Total services
5,149
Distinct HCPCS
21
Medicare payment
$400K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 447 Ophthalmology providers in MD — above median (cohort median 2,862).
PRESCRIBING · PART D · 2024
Total Rx claims
1,442
Beneficiaries
—
Total drug cost
$495K
Distinct drugs
14
Brand share
23.6%
Top prescribed drugs
Latanoprost425 claims
Prednisolone Acetate197 claims
Brimonidine Tartrate195 claims
Aflibercept137 claims
Ketorolac Tromethamine114 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
100.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$38
Payment records
2
By payment type
Food and Beverage$38
Top paying entities
Food and Beverage$38